Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/17222
Endometriosis: alternative methods of medical treatment
WOS ID: 000214750800062
Scopus EID: 2-s2.0-84936866067
Embase PUI: L605124104
StatisticsItem usage statistics
MetadataShow Dublin Core item record
Document typeresearch article
CitationMuñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-Garcia A, Lopez-Gonzalez G, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015;7:595-603.
Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although in most women a combination of both treatments is required. Long-term medical treatment is usually needed in most women. Unfortunately, in most cases, pain symptoms recur between 6 months and 12 months once treatment is stopped. The authors conducted a literature search for English original articles, related to new medical treatments of endometriosis in humans, including articles published in PubMed, Medline, and the Cochrane Library. Keywords included endometriosis matched with medical treatment, new treatment, GnRH antagonists, Aromatase inhibitors, selective progesterone receptor modulators, anti-TNF alpha, and antiangiogenic factors. Hormonal treatments currently available are effective in the relief of pain associated to endometriosis. Among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies. GnRh antagonists are expected to be as effective as GnRH agonists, but with easier administration (oral). There is a need to find effective treatments that do not block the ovarian function. For this purpose, antiangiogenic factors could be important components of endometriosis therapy in the future. Upcoming researches and controlled clinical trials should focus on these drugs.
Keywordspharmacological treatment options
selective progesterone receptor modulators